The HIV Investment Case -- Uganda Presented by Karusa Kiragu, - - PowerPoint PPT Presentation

▶
the hiv investment case uganda
SMART_READER_LITE
LIVE PREVIEW

The HIV Investment Case -- Uganda Presented by Karusa Kiragu, - - PowerPoint PPT Presentation

Mar 21, 2023 242 likes •407 views

The HIV Investment Case -- Uganda Presented by Karusa Kiragu, UNAIDS Country Director, Uganda and John Stover, Avenir Health, USA Tuesday January 28, 2020 SENSITIVE BUT UNCLASSIFIED What is an HIV Investment Case? The HIV Investment Case

slide-1
SLIDE 1

SENSITIVE BUT UNCLASSIFIED

The HIV Investment Case -- Uganda

Presented by Karusa Kiragu, UNAIDS Country Director, Uganda and John Stover, Avenir Health, USA Tuesday January 28, 2020

slide-2
SLIDE 2

SENSITIVE BUT UNCLASSIFIED

What is an HIV Investment Case?

  • The HIV Investment Case is a value proposition which describes how

the Uganda government, working together with its partners and stakeholders, will help to improve the HIV response over the next 10 years.

  • It describes how a stronger, more efficient and results-oriented

government will serve the people of Uganda to achieve established targets.

  • It makes the argument why the solutions Uganda proposes, will be

able to solve the problem based on:

  • Understanding the HIV situation
  • ‘Designing efficient programs
  • Delivering at scale and
  • Sustaining for impact with adequate funding.
slide-3
SLIDE 3

SENSITIVE BUT UNCLASSIFIED

How is it being done?

  • Leadership: Uganda AIDS Commission and the AIDS Control

Program

  • Advisors: Technical working group comprised of several thematic

areas (HIV Prevention; Care and Treatment; Social Support; Systems Strengthening); guided by a steering committee

  • Expertise: Will be prepared by the same team that did the last

HIV Investment Case for Uganda

  • Consultations: Participatory consultations with stakeholders
  • Process: Modelling various intervention scenarios and projecting

HIV outcomes to find the most optimal for the investment

slide-4
SLIDE 4

SENSITIVE BUT UNCLASSIFIED

What will be the product?

The final product is a document which explains:

  • 1. What are the results of the current investments?
  • 2. How much should Uganda spend in the future and

what will Uganda get?

  • 3. What needs to be improved?
  • 4. Where will the money come from?
slide-5
SLIDE 5

SENSITIVE BUT UNCLASSIFIED

How will it be used?

  • 1. To inform the HIV National Strategic Plan
  • 2. To inform the Global Fund application
  • 3. To support other financing dialogues
slide-6
SLIDE 6

SENSITIVE BUT UNCLASSIFIED

Modeling to Support the Development of the NSP and the Investment Case

28 January 2020

slide-7
SLIDE 7

SENSITIVE BUT UNCLASSIFIED

National HIV and AIDS Strategic Plan 2015/16 – 2019/20

Zero new HIV infections, zero HIV- related mortality, zero stigma Prevention Care and treatment Social support and protection Systems strengthening

slide-8
SLIDE 8

SENSITIVE BUT UNCLASSIFIED

Modeling for the NSP

Inputs

  • Pop data
  • Surveys
  • Program data
  • Unit costs

Targets

  • Prevention
  • Tx cascade
  • Social enablers
  • Efficiencies

Model calculations

  • Need for services
  • Behaviors
  • Transmission
  • Progression
  • Mortality

Services provided

  • Intervention
  • Population group

Outputs

  • New infections
  • AIDS deaths
  • Cost
  • Cost-

effectiveness

slide-9
SLIDE 9

SENSITIVE BUT UNCLASSIFIED

Constant Coverage

10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 2010 2015 2020 2025 2030

New HIV Infections

Constant 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 2010 2015 2020 2025 2030

AIDS-Related Deaths

Constant

slide-10
SLIDE 10

SENSITIVE BUT UNCLASSIFIED

Achieving global targets

10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 2010 2015 2020 2025 2030

New HIV Infections

Constant Targets 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 2010 2015 2020 2025 2030

AIDS-Related Deaths

Constant Targets

Target scenario achieves UNAIDS updated Fast-Track targets. Stars represent 75%/90% reduction from 2010 to 2020/2030.

slide-11
SLIDE 11

SENSITIVE BUT UNCLASSIFIED

Epidemic transition: Targets achieved

0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 2010 2012 2014 2016 2018 2020 2022 2024 2026 2028 2030

Incidence – Mortality Ratio

Ratio Target 0.01 0.02 0.03 0.04 0.05 0.06 0.07 0.08 0.09 2010 2012 2014 2016 2018 2020 2022 2024 2026 2028 2030

Incidence – Prevalence Ratio

Ratio Target

slide-12
SLIDE 12

SENSITIVE BUT UNCLASSIFIED

Importance of addressing social enablers

10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 2010 2015 2020 2025 2030

New HIV Infections

Constant Targets No Social Enablers 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 2010 2015 2020 2025 2030

AIDS-Related Deaths

Constant Targets No Social Enablers

Social enablers: Programs to address stigma, gender-based violence, decriminalization, human rights

slide-13
SLIDE 13

SENSITIVE BUT UNCLASSIFIED

Resources Needed

$0 $200 $400 $600 $800 $1,000 $1,200 $1,400 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030

Millions

Base Targets

Funding gap

slide-14
SLIDE 14

SENSITIVE BUT UNCLASSIFIED

Closing the funding gap: optimizing allocation and improving implementation efficiency

5,000 10,000 15,000 20,000 25,000 30,000 35,000 40,000 45,000 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030

New HIV Infections

Optimized = Current spending optimized for maximum prevention Implementation efficiencies = Optimized plus implementation changes to reduce costs Constant coverage Constant expenditures (optimized) Implementation efficiencies Targets achieved

slide-15
SLIDE 15

SENSITIVE BUT UNCLASSIFIED

NSP Components

Prevention

  • Condoms
  • VMMC
  • PMTCT
  • PrEP
  • PEP
  • Combination

prevention for key populations

  • Combination

prevention for AGYW

  • Services for priority

populations

Treatment

  • HIV testing services
  • Linkage to care
  • ART delivery
  • Adherence support

Social enablers

  • Reduce stigma
  • Prevent gender-based

violence

  • Decriminalize behaviors

Social protection and support

  • Human rights
  • OVC

System strengthening

  • Governance
  • Financial sustainability
  • Human resources
  • Service delivery
  • Research